What is the story about?
What's Happening?
Oobli, a company specializing in sweet proteins derived from fruits, has received a 'no questions' letter from the FDA for its brazzein-54 protein, confirming its status as generally recognized as safe (GRAS). This protein, sourced from the oubli fruit, offers sugar-like sweetness without impacting blood sugar levels or the gut microbiome. Oobli's sweet proteins can replace a significant portion of sugar in various food products, including sodas and baked goods. The FDA's approval follows Oobli's partnerships with companies like Grupo Bimbo and Ingredion to expand production and application of these proteins.
Why It's Important?
The FDA's approval of Oobli's sweet proteins marks a significant advancement in the food industry, offering a healthier alternative to traditional sugar. This development is crucial as it addresses growing consumer demand for low-sugar products without compromising taste. The ability to replace sugar in foods can lead to healthier dietary options, potentially reducing the prevalence of obesity and diabetes. Oobli's partnerships with major food companies indicate a shift towards more sustainable and health-conscious food production practices.
AI Generated Content
Do you find this article useful?
